These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19852814)

  • 1. Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania).
    van Beekhuizen HJ; Pembe AB; Fauteck H; Lotgering FK
    BMC Pregnancy Childbirth; 2009 Oct; 9():48. PubMed ID: 19852814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial on the value of misoprostol for the treatment of retained placenta in a low-resource setting.
    van Beekhuizen HJ; Tarimo V; Pembe AB; Fauteck H; Lotgering FK
    Int J Gynaecol Obstet; 2013 Sep; 122(3):234-7. PubMed ID: 23791153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical vein injection of misoprostol versus normal saline for the treatment of retained placenta: intrapartum placebo-controlled trial.
    Rajab SS; Alalaf SK
    BMC Pregnancy Childbirth; 2014 Jan; 14():37. PubMed ID: 24444360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No reduction of manual removal after misoprostol for retained placenta: a double-blind, randomized trial.
    van Stralen G; Veenhof M; Holleboom C; van Roosmalen J
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):398-403. PubMed ID: 23231499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT.
    Denison FC; Carruthers KF; Hudson J; McPherson G; Scotland G; Brook-Smith S; Clarkson C; Peace M; Brewin J; Chua GN; Hallowell N; Norman JE; Lawton J; Norrie J
    Health Technol Assess; 2019 Dec; 23(70):1-72. PubMed ID: 31912780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised placebo controlled trial of oral misoprostol in the third stage of labour.
    Hofmeyr GJ; Nikodem VC; de Jager M; Gelbart BR
    Br J Obstet Gynaecol; 1998 Sep; 105(9):971-5. PubMed ID: 9763047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different routes and forms of uterotonics for treatment of retained placenta: a randomized clinical trial.
    Maher MA; Sayyed TM; Elkhouly NI
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2179-2184. PubMed ID: 27677547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical vein injection of 400 versus 800 μg misoprostol for the treatment of retained placenta: A multicenter, randomized double-blind controlled trial.
    Alalaf SK; Al Tawil NG; Jawad AK; Mahmoud MB; Muhamad BQ; Abdul Rahman KH; Sileem SA; Hassan JN; Ameen KM; Mustafa SA; Bawadikji AA
    J Obstet Gynaecol Res; 2020 May; 46(5):727-735. PubMed ID: 32157797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.
    Denison FC; Carruthers KF; Hudson J; McPherson G; Chua GN; Peace M; Brewin J; Hallowell N; Scotland G; Lawton J; Norrie J; Norman JE;
    PLoS Med; 2019 Dec; 16(12):e1003001. PubMed ID: 31887169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consecutive intra-umbilical vein injection of misoprostol and intravenous sulprostone in the management of retained placenta.
    Notten F; Meertens L; Wissink B; Scheepers HC
    Arch Gynecol Obstet; 2014 Jan; 289(1):35-40. PubMed ID: 23771186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
    Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G
    BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial protocol.
    Gattás DSMB; da Silva Junior JR; Souza ASR; Feitosa FE; de Amorim MMR
    Reprod Health; 2018 Apr; 15(1):65. PubMed ID: 29669596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocolysis for management of retained placenta.
    Abdel-Aleem H; Abdel-Aleem MA; Shaaban OM
    Cochrane Database Syst Rev; 2011 Jan; (1):CD007708. PubMed ID: 21249693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
    Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
    Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta.
    Rogers MS; Yuen PM; Wong S
    Acta Obstet Gynecol Scand; 2007; 86(1):48-54. PubMed ID: 17230289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial.
    Gattás DSMB; de Amorim MMR; Feitosa FEL; da Silva-Junior JR; Ribeiro LCG; Souza GFA; Souza ASR
    Reprod Health; 2020 Apr; 17(1):47. PubMed ID: 32272959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of sequential use of oxytocin and sublingual nitroglycerin in the cases of retained placenta.
    Kashanian M; Hasankhani S; Sheikhansari N; Bahasadri S; Homam H
    J Matern Fetal Neonatal Med; 2016 Oct; 29(20):3254-9. PubMed ID: 26701364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor.
    Vaid A; Dadhwal V; Mittal S; Deka D; Misra R; Sharma JB; Vimla N
    Arch Gynecol Obstet; 2009 Dec; 280(6):893-7. PubMed ID: 19277690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
    Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT
    Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual compared with vaginal misoprostol for labour induction at term: a randomised controlled trial.
    Bartusevicius A; Barcaite E; Krikstolaitis R; Gintautas V; Nadisauskiene R
    BJOG; 2006 Dec; 113(12):1431-7. PubMed ID: 17083652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.